Advertisement

The Latest

Altamonte Springs, Fla.-based AdventHealth’s approach to patient experience is rooted in a belief that goes beyond clinical outcomes, according to Tim Cook, the system’s senior vice president and chief mission integration officer.  The belief is that every patient “is a…

The pipeline of healthcare CFO talent is tightening, and the problem runs deeper than a shortage of qualified candidates, according to a June 3 report from executive search firm WittKieffer.  The issue is one of readiness at scale, according to…

Andrew Morgan has been named chief strategy officer for Altamonte Springs, Fla.-based AdventHealth’s mid-America region, according to a June 4 LinkedIn post. Prior to his new role, Mr. Morgan served as president of Cincinnati, Ohio-based Bon Secours Mercy Health’s Tiffin…

Carrie Adams, PharmD, was promoted from COO to president of Meritus Medical Center in Hagerstown, Md. Dr. Adams has served as COO of the 327-bed, level III trauma center since 2022, overseeing clinical operations, quality, performance improvement and support services.…

York, Pa.-based WellSpan Health and Royal Philips announced a seven-year strategic alliance on June 4 that brings advanced imaging and diagnostics technology to patients across central Pennsylvania and northern Maryland and establishes a joint research and innovation collaboration. The deal…

Healthcare employment rose by 35,200 in May, in line with the 12-month average of 38,000 monthly job gains, according to the U.S. Bureau of Labor Statistics. The bureau released the jobs report June 5. Here are three more takeaways: 1.…

Capital Blue Cross and Bethlehem, Pa.-based St. Luke’s University Health Network have collaborated on a health plan option, now available to some employers. Rates for the Valley Advantage EPO are below those for Capital’s standard PPO, according to a June…

Drugmakers, patient advocates and public health experts have urged the FDA to pause or significantly revise its priority voucher program during the agency’s first public hearing on the initiative June 4. Critics cited concerns about transparency, political influence and the…

The FDA’s Center for Drug Evaluation and Research has accepted the first letter of intent for an in silico drug development tool into the agency’s Innovative Science and Technology Approaches for New Drugs qualification program. The tool, an AI-Driven Digital…

Advertisement